Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
The Zacks Analyst Blog Highlights: ExxonMobil, Procter & Gamble, Micron, Macy's and Alexion Pharmaceuticals

The Zacks Analyst Blog Highlights: ExxonMobil, Procter & Gamble, Micron, Macy's and Alexion Pharmaceuticals

Research Reports on Exxon, P&G and the Q4 Earnings Season

Research Reports on Exxon, P&G and the Q4 Earnings Season

4 Top Biotech Mutual Funds for 2017

Biotechnology shares have welcomed this year in style, marking a striking reversal from last year???s dismal performance

FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ:ALXN)...

Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again

Drug stocks were hit once again with President-elect Donald Trump's comments about the sector at his first news conference since his election in November.

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline - January 17, 2017

NEW YORK, NY / ACCESSWIRE / January 11, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU

Alexion (ALXN) has filed regulatory applications in both the U.S. and EU for Soliris for the treatment of patients with refractory generalized myasthenia gravis.

Blog Coverage Alexion Pharma Applies for US and EU Marketing Approval of Refractory Generalized Myasthenia Gravis Medicine

Upcoming AWS Coverage on Jazz Pharmaceuticals

Alexion Blood Disorder Drug Gets Orphan Designation in U.S.

Alexion (ALXN) announced that the FDA has granted orphan drug designation to ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 7, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN)

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead plaintiff applications...

Company News for January 06, 2017

Companies In The News are: ALXN,CEB,IT,SHLD,SWK,HALO

FDA Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting...

Macy's and Toyota skid; Sears jumps

NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday:

ALXN ALERT: Rosen Law Firm Reminds Alexion Pharmaceuticals, Inc. Investors of Important January 17 Deadline in Class Action - ALXN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Alexion Pharmaceuticals, Inc. securities (NASDAQ:ALXN) from February 10, 2014 through November 9, 2016, inclusive (the "Class Period")...

Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained

Alexion (ALXN) has finally announced the filing of its Form 10-Q with the SEC for the period ended Sep 30, 2016 and retained its outlook for 2016.

Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Alexion Pharmaceuticals, Inc. (NASDAQGS: ALXN) in the U.S. District Court for the...

Alexion (ALXN): Will the Stock Continue to Suffer in 2017?

Given the delay in filing the 10-Q, departure of key executives, pipeline setbacks and the ongoing drug pricing issues, Alexion seems to be heading toward difficult times in 2017.

Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation

Although this was a relatively slow week for the biotech sector, Inotek (ITEK) made it to the headlines on disappointing data on its lead pipeline drug.

ALXN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alexion Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Alexion Pharmaceuticals, Inc....

Van Meerten Stock Picks

5 Small Caps for Momentum Investors
Today I wanted to find 5 Small Cap stocks with great current momentum so I used Barchart to sort the S&P 600 Small Cap Index stocks first for the most frequent new highs in the last month, then again for technical buy signals of 80.
UTEK +0.26 , CMO +0.01 , LMOS +0.12 , VRTV +0.40 , AFAM -0.35
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH17 +0.18%) are up +0.15% and European stocks are up +0.36% on signs of strength in the global economy after China Q4 GDP grew more than expected. The markets are also awaiting any signals from... Read More

Chart of the Day

Liberty Broadband Communications (LBRDA) is the Barchart Chart of the Day.  The cable TV company has a Trend Spotter buy signal, a Weighted Alpha of 61.85+ and gained 64.77% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures settled mostly 3 cents higher, rising 11 1/4 cents on the week. Weekly US export data this morning showed sales of 1,379,917 MT, within expectations, with 12,300 MT of that coming from the 17/18 marketing year. Sales are 127% above last ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.